Drugs / CHERRY JUICE
CHERRY JUICE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06268665 | Aug 2024 → Oct 2027 expected | female breast carcinoma, invasive breast carcinoma, ovarian carcinoma, uterine adnexa cancer | University of California, Davis | Recruiting | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHERRY JUICE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108181 ↗ |
| Known as | Prunus cerasus (bitter cherry) juice | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108181 ↗ |
| Known as | Prunus cerasus fruit juice | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108181 ↗ |
| Known as | Sour cherry fruit juice | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108181 ↗ |
| Known as | Sour cherry juice | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108181 ↗ |
| Known as | Tart Cherry Juice | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06268665 ↗ |
| Route | Oral | “Given PO” NCT06268665 ↗ |